Orchid receives US FDA approval for Cefdinir (PharmaBiz)
The Chennai-based pharma major, Orchid Chemicals and Pharmaceuticals Ltd (Orchid) has received approval from the US FDA for its Abbreviated New Drug Application (ANDAs) for Cefdinir capsules 300 mg and Cefdinir for oral suspension 125 mg/5 ml and 250 mg/5 ml.